Skip to content

Postoperative Pain Management in laparoscopic cholecystectomy patients using Duloxetine

Evaluating the effect of Duloxetine premedication on postoperative analgesic requirement in patients undergoing laparoscopic cholecystectomy surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034291
Enrollment
60
Registered
2021-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Capsule Duloxetine 60mg: Capsule Duloxetine 60 mg Stat dose per orally, will be given 2 hours prior to laparoscopic cholecystectomy operation for better analgesia.Patient will be chosen

Sponsors

Sharda Hospital School of Medical Sciences Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All the elective cases of Laparoscopic Cholecystectomy of ASA I or II, scheduled for general anesthesia

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Patients with any known history of cardiovascular diseases 3.Patients with known case of hepatic and renal disease 4.Patients with known history of substance abuse 5.A chronic opioid abuser( >3 months), being on chronic Gabapentin or Pregabalin( >3months) 6.Patients on antidepressant drugs and patients with psychiatric disorders 7.Anticipitated difficult airway on preoperative assessment 8.Patients converted to open cholecystectomy from laparoscopic cholecystectomy 9. Patients in whom drain placement has been done 10.BMI >30 11.Pregnant and lactating females 12.History of allergy to any of the drug to be administered

Design outcomes

Primary

MeasureTime frame
To evaluate the analgesic efficacy of duloxetine premedication on post operative analgesic requirement in laparoscopic cholecystectomies using VAS score(Visual Analogue Scale)Timepoint: 12 hours

Secondary

MeasureTime frame
a) Total dose of first and second rescue analgesic (InjParacetamol&InjTramadol) consumption in post operative period. b) Ramsey Sedation Score in Preoperative & postoperative period c) Hemodynamic changes d) Demographic data e) Incidence of side effects (if any)Timepoint: 12 hours

Countries

India

Contacts

Public ContactDr Ambhrin Saha

School of Medical Sciences & Research

doc.shivi45@gmail.com9999096812

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026